SYNCOM FORMULATIONS (INDIA)
Back to Balance Sheet
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹5.41 Cr | ₹4.17 Cr | ₹3.30 Cr | ₹2.69 Cr | ₹1.71 Cr |
What is the latest Long Term Provisions ratio of SYNCOM FORMULATIONS (INDIA) ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹5.41 Cr |
| Mar2025 | ₹4.17 Cr |
| Mar2024 | ₹3.30 Cr |
| Mar2023 | ₹2.69 Cr |
| Mar2022 | ₹1.71 Cr |
How is Long Term Provisions of SYNCOM FORMULATIONS (INDIA) Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹5.41 Cr | 29.85 | |
| Mar2025 | ₹4.17 Cr | 26.15 | |
| Mar2024 | ₹3.30 Cr | 22.73 | |
| Mar2023 | ₹2.69 Cr | 57.43 | |
| Mar2022 | ₹1.71 Cr | - | |
Compare Long Term Provisions of peers of SYNCOM FORMULATIONS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNCOM FORMULATIONS (INDIA) | ₹2,180.8 Cr | -0.2% | 15.1% | 41.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,067.0 Cr | -2.3% | -5.9% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,983.0 Cr | -1.7% | -1.1% | 60.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,974.0 Cr | -2.1% | -5.1% | 32.2% | Stock Analytics | |
| CIPLA | ₹106,130.0 Cr | -2.2% | -4% | -13.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,707.0 Cr | 1.8% | 7.6% | -4.3% | Stock Analytics | |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNCOM FORMULATIONS (INDIA) | -0.2% |
15.1% |
41.4% |
| SENSEX | -0.6% |
-4.8% |
-11.4% |
You may also like the below Video Courses